We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Benitec’s Gene Silencing Technology Used by Johns Hopkins’ Scientists in the Development of a Treatment for Radio-Resistant Prostate Cancer

Product News   Jun 03, 2011

 
Benitec’s Gene Silencing Technology Used by Johns Hopkins’ Scientists in the Development of a Treatment for Radio-Resistant Prostate Cancer
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research

Product News

Flow Eighteen38 and FairJourney Biologics S.A. have announced an agreement with the Hubrecht Institute to harness the potential of FJB’s proprietary llama naïve libraries to develop antibodies to be used as research tools.

READ MORE

Cmed Group Joins AIXIAL, the CRO of ALTEN Group

Product News

AIXIAL, the CRO of ALTEN Group, announces the acquisition of UK headquartered CMED Group by ALTEN EUROPE.

READ MORE

H.E.L Group Appoints Sales Director for Asia-Pacific

Product News

H.E.L Group has announced the appointment of Oh Chee Keat (Brice Oh) as Regional Sales Director for Asia-Pacific.

READ MORE

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE